Urška Kamenšek

1.2k total citations
52 papers, 841 citations indexed

About

Urška Kamenšek is a scholar working on Biotechnology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Urška Kamenšek has authored 52 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Biotechnology, 28 papers in Molecular Biology and 14 papers in Biomedical Engineering. Recurrent topics in Urška Kamenšek's work include Microbial Inactivation Methods (35 papers), Virus-based gene therapy research (12 papers) and Microfluidic and Bio-sensing Technologies (12 papers). Urška Kamenšek is often cited by papers focused on Microbial Inactivation Methods (35 papers), Virus-based gene therapy research (12 papers) and Microfluidic and Bio-sensing Technologies (12 papers). Urška Kamenšek collaborates with scholars based in Slovenia, Italy and United States. Urška Kamenšek's co-authors include Maja Čemažar, Gregor Serša, Simona Kranjc, Emanuela Signori, Špela Kos, Justin Teissié, Damijan Miklavčič, Guillermo Marshall, Urša Lampreht Tratar and Tanja Jesenko and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Urška Kamenšek

50 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urška Kamenšek Slovenia 17 557 370 252 243 135 52 841
P. Urbas United States 9 386 0.7× 319 0.9× 225 0.9× 308 1.3× 267 2.0× 12 814
Urša Lampreht Tratar Slovenia 15 323 0.6× 195 0.5× 161 0.6× 145 0.6× 120 0.9× 30 579
Darja Pavlin Slovenia 13 286 0.5× 208 0.6× 129 0.5× 106 0.4× 60 0.4× 24 507
Cristian Capasso Finland 16 119 0.2× 388 1.0× 114 0.5× 210 0.9× 323 2.4× 23 709
Tanja Dolinšek Slovenia 15 283 0.5× 190 0.5× 135 0.5× 91 0.4× 53 0.4× 15 399
Peter Kulmburg Germany 16 129 0.2× 572 1.5× 157 0.6× 468 1.9× 281 2.1× 32 1.2k
Zhenguo Cheng China 19 138 0.2× 458 1.2× 114 0.5× 181 0.7× 405 3.0× 40 929
Johannes Fruehauf United States 12 135 0.2× 559 1.5× 107 0.4× 46 0.2× 80 0.6× 20 783
Helena Villanueva Spain 15 133 0.2× 532 1.4× 86 0.3× 351 1.4× 226 1.7× 28 867
Beatriz Martins Finland 14 66 0.1× 266 0.7× 114 0.5× 218 0.9× 317 2.3× 20 598

Countries citing papers authored by Urška Kamenšek

Since Specialization
Citations

This map shows the geographic impact of Urška Kamenšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urška Kamenšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urška Kamenšek more than expected).

Fields of papers citing papers by Urška Kamenšek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urška Kamenšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urška Kamenšek. The network helps show where Urška Kamenšek may publish in the future.

Co-authorship network of co-authors of Urška Kamenšek

This figure shows the co-authorship network connecting the top 25 collaborators of Urška Kamenšek. A scholar is included among the top collaborators of Urška Kamenšek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urška Kamenšek. Urška Kamenšek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamenšek, Urška, et al.. (2025). Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination. Frontiers in Immunology. 16. 1470432–1470432. 1 indexed citations
2.
Scattolin, Thomas, Dario R. Alessi, Isabella Caligiuri, et al.. (2025). Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy. Dalton Transactions. 54(11). 4685–4696. 4 indexed citations
3.
Erman, Andreja, et al.. (2024). Establishment of Mouse Orthotopic Urinary Bladder Tumor Model and Its Analysis by Light and Electron Microscopy. Methods in molecular biology. 2773. 33–49.
4.
Kamenšek, Urška, Maja Čemažar, Simona Kranjc, et al.. (2023). What We Learned about the Feasibility of Gene Electrotransfer for Vaccination on a Model of COVID-19 Vaccine. Pharmaceutics. 15(7). 1981–1981. 1 indexed citations
5.
Kamenšek, Urška, Urša Lampreht Tratar, Simona Kranjc, et al.. (2023). Gene Immunotherapy of Colon Carcinoma with IL-2 and IL-12 Using Gene Electrotransfer. International Journal of Molecular Sciences. 24(16). 12900–12900. 8 indexed citations
6.
Serša, Gregor, et al.. (2022). Tumor cell-based vaccine contributes to local tumor irradiation by eliciting a tumor model-dependent systemic immune response. Frontiers in Immunology. 13. 974912–974912. 4 indexed citations
7.
8.
Kos, Špela, Maša Bošnjak, Tanja Jesenko, et al.. (2021). Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids Encoding Human or Murine IL-12 Intended for First-in-Human Clinical Study. Pharmaceutics. 13(10). 1739–1739. 12 indexed citations
9.
Kamenšek, Urška, et al.. (2021). Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer. Bioelectrochemistry. 140. 107831–107831. 13 indexed citations
10.
Kos, Špela, Urška Kamenšek, Maja Čemažar, et al.. (2021). Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. Journal of Controlled Release. 332. 623–635. 34 indexed citations
11.
12.
Žegura, Bojana, et al.. (2018). Adipose tissue stem cell-derived hepatic progenies as an in vitro model for genotoxicity testing. Archives of Toxicology. 92(5). 1893–1903. 3 indexed citations
13.
Jesenko, Tanja, Urška Kamenšek, Stine K. Frandsen, et al.. (2018). Effect of calcium electroporation on tumour vasculature. Scientific Reports. 8(1). 9412–9412. 40 indexed citations
14.
Kos, Špela, Urška Kamenšek, Maja Čemažar, et al.. (2017). Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma. Bioelectrochemistry. 119. 161–171. 41 indexed citations
15.
Kos, Špela, Tanja Blagus, Maja Čemažar, et al.. (2016). Electrotransfer parameters as a tool for controlled and targeted gene expression in skin. Molecular Therapy — Nucleic Acids. 5(8). e356–e356. 25 indexed citations
16.
Kamenšek, Urška, Marie‐Pierre Rols, Maja Čemažar, & Muriel Golzio. (2016). Visualization of Nonspecific Antitumor Effectiveness and Vascular Effects of Gene Electro-Transfer to Tumors. Current Gene Therapy. 16(2). 90–97. 6 indexed citations
17.
Kamenšek, Urška, Gregor Serša, Nataša Tozon, et al.. (2015). Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines. The Journal of Membrane Biology. 248(5). 909–917. 12 indexed citations
18.
Kamenšek, Urška, Gregor Serša, & Maja Čemažar. (2013). Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model. Molecular Cancer. 12(1). 136–136. 15 indexed citations
19.
Kamenšek, Urška, et al.. (2010). Irradiation, Cisplatin, and 5-Azacytidine Upregulate Cytomegalovirus Promoter in Tumors and Muscles: Implementation of Non-invasive Fluorescence Imaging. Molecular Imaging and Biology. 13(1). 43–52. 21 indexed citations
20.
Pavlin, Darja, Maja Čemažar, Urška Kamenšek, et al.. (2009). Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma. Cancer Biology & Therapy. 8(22). 2114–2122. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Urbas Breakdown of academic impact, for papers by Urša Lampreht Tratar Breakdown of academic impact, for papers by Darja Pavlin Breakdown of academic impact, for papers by Cristian Capasso Breakdown of academic impact, for papers by Tanja Dolinšek Breakdown of academic impact, for papers by Peter Kulmburg Breakdown of academic impact, for papers by Zhenguo Cheng Breakdown of academic impact, for papers by Johannes Fruehauf Breakdown of academic impact, for papers by Helena Villanueva Breakdown of academic impact, for papers by Beatriz Martins
Rankless by CCL
2026